Health and Fitness Health and Fitness
Wed, November 2, 2011
[ Wed, Nov 02nd 2011 ] - Market Wire
Marina Biotech Demonstrates That Its Novel UsiRNA .. totoxicity Resulting From microRNA-Like Off-Targe
[ Wed, Nov 02nd 2011 ] - Market Wire
Given Imaging Announces New Data Underscore Value of ManoScan(TM) AR in Patients With Incontinence
[ Wed, Nov 02nd 2011 ] - Market Wire
Implant Sciences Signs Cooperative Research && .. nt With TSL S&;;T, a Directorate of the
[ Wed, Nov 02nd 2011 ] - Market Wire
Medivation Announces Third Quarter Financial Resu .. ts Teleconference and Webcast on November 9, 2011
[ Wed, Nov 02nd 2011 ] - Market Wire
MELA Sciences Announces FDA Approval for MelaFind(R)
[ Wed, Nov 02nd 2011 ] - Market Wire
New Studies Show GERD Is Best Assessed Off PPI Therapy
[ Wed, Nov 02nd 2011 ] - Market Wire
Threshold Pharmaceuticals Appoints Nipun Davar as .. t of Pharmaceutical Development and Manufacturing
Tue, November 1, 2011
[ Tue, Nov 01st 2011 ] - Market Wire
Experts Report that Abbott's New PLEX-ID Assay Of .. ortant Testing Capabilities for Biothreat Defense
[ Tue, Nov 01st 2011 ] - Market Wire
Alkermes' Corporate Presentation to be Webcast at 2011 Annual Credit Suisse Health Care Conference
[ Tue, Nov 01st 2011 ] - Market Wire
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
[ Tue, Nov 01st 2011 ] - Market Wire
Solta and Medicis Announce Close of Agreement for LIPOSONIX
[ Tue, Nov 01st 2011 ] - Market Wire
Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update
[ Tue, Nov 01st 2011 ] - Market Wire
INSYS Therapeutics Announces Commercial Team Additions
[ Tue, Nov 01st 2011 ] - Market Wire
Theravance to Present at Investor Conferences in November 2011
[ Tue, Nov 01st 2011 ] - Market Wire
ISTA Pharmaceuticals Reports Third Quarter 2011 Financial Results
[ Tue, Nov 01st 2011 ] - Market Wire
Critical Outcome Technologies Inc. to Deliver Pod .. on on COTI-2 at Influential Scientific Conference
[ Tue, Nov 01st 2011 ] - Market Wire
Syneron Sets New Facial Rejuvenation Standard Wit .. t the American Society of Dermatologic Surgery Co
[ Tue, Nov 01st 2011 ] - Market Wire
Immunovaccine to Report Q3 2011 Financial Results and Conference Call
[ Tue, Nov 01st 2011 ] - Market Wire
Professional Outlook, Will EU's Deal Hold the Mar .. ign Technology, Inc. and IDEXX Laboratories, Inc.
[ Tue, Nov 01st 2011 ] - Market Wire
RepliCel Provides Update on First-in-man Clinical Trials and Recent Corporate Activity
[ Tue, Nov 01st 2011 ] - Market Wire
Equity Research on Pharmaceutical Product Develop .. cs Inc. - Acquisitions and Privatizations Dominat
[ Tue, Nov 01st 2011 ] - Market Wire
Novadaq to Present at November Investor Healthcare Conferences
[ Tue, Nov 01st 2011 ] - Market Wire
Aeolus Pharmaceuticals Announces Positive Results .. Neupogen(R) as Combination Therapy for Treatment
[ Tue, Nov 01st 2011 ] - Market Wire
Cytokinetics Announces Initiation of Second Cohor .. l Trial Evaluating CK-2017357 in Patients With AL
[ Tue, Nov 01st 2011 ] - Market Wire
Implant Sciences' Explosives Trace Detector Deployed at Middle East Embassy
[ Tue, Nov 01st 2011 ] - Market Wire
SciClone Pharmaceuticals to Report Third Quarter 2011 Financial Results on November 8
[ Tue, Nov 01st 2011 ] - Market Wire
Imaging3, Inc. FDA 510(k) Protocol Meeting Update
[ Tue, Nov 01st 2011 ] - Market Wire
VentriPoint Commences Clinical Studies of Pulmona .. ension Application of Right Heart Analysis System
[ Tue, Nov 01st 2011 ] - Market Wire
Reflect Scientific, Inc. Strengthens Liquid Nitrogen Cooling Intellectual Property Position
[ Tue, Nov 01st 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference

Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference


Published on 2011-11-01 02:41:20 - Market Wire
  Print publication without navigation


November 01, 2011 05:00 ET

Threshold Pharmaceuticals to Present at the Lazard Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Nov 1, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: [ THLD ]) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 8th Annual Lazard Healthcare Conference in New York City on Tuesday, November 15, 2011 at 10:00AM EST.

A live webcast of the presentation will be available under the Webcast section of the Company's Website at [ www.thresholdpharm.com ]

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ([ www.thresholdpharm.com ]).


Contributing Sources